THE EMA’s Pharmacovigilance
Risk Assessment Committee started
a safety review of Diane 35
(cyproterone acetate 2 mg,
ethinylestradiol 35μg), and its
generics following the decision by
French authorities to suspend the
drugs’ approval over safety
concerns around venous and
arterial thromboembolism.The above article was sent to subscribers in Pharmacy Daily's issue from 14 Feb 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Feb 13
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.